Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3โ4 weeks
ANKRD26 Gene Thrombocytopenia Type 2 Genetic Test in Dubai
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited next-generation sequencing.
- Premium Logistics: VIP mobile phlebotomy with temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test interpretation with a DHA-licensed genetic counsellor.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The ANKRD26 Gene Thrombocytopenia Type 2 Genetic Test detects pathogenic variants in the ANKRD26 gene responsible for inherited thrombocytopenia-2 (THC2), a bleeding disorder characterised by low platelet counts. This DHA-compliant assay delivers definitive molecular confirmation for at-risk families and informs personalised haematological management. Next-generation sequencing (NGS) is employed to provide full gene coverage, identifying point mutations, small insertions and deletions, and copy number changes with high analytical sensitivity.
| Feature | Our Test (NGS Panel) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next-generation sequencing (NGS) โ full gene coverage | Sanger sequencing โ limited to known hotspots |
| Analytical Sensitivity | >99.9% | ~95% for targeted regions |
| Turnaround Time | 3โ4 weeks | 4โ6 weeks |
| Variant Detection | Point mutations, small indels, copy number changes | Point mutations only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (DHA Registration ID: 9294403), Consultant Medical Genetics, states: โA confirmed pathogenic variant in ANKRD26 necessitates correlation with the full haematological profile and three-generation pedigree. I recommend that all family members of a proband receive targeted genetic counselling before pursuing cascade screening, and that patients maintain their current medication regimen until formally reviewed by their specialist.โ
Medication Advisory
โ ๏ธ Do not stop or modify any anticoagulant, anti-platelet, or prescribed therapy without prior discussion with your treating physician. Sudden changes may elevate bleeding risk.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Individuals unable to provide informed consent, those experiencing active severe haemorrhage requiring urgent intervention, or patients who cannot safely undergo phlebotomy.
- ER Red Flags: Sudden onset of extensive bruising, petechiae (pinpoint red spots), mucosal bleeding (nose, gums), blood in urine or stool, or any indication of intracranial bleeding โ seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the ANKRD26 gene test and why is it performed?
This advanced genetic test identifies mutations in the ANKRD26 gene that cause thrombocytopenia type 2, a hereditary bleeding disorder characterised by persistently low platelet counts. It confirms the diagnosis in symptomatic individuals, enables predictive testing for at-risk family members, and helps haematologists tailor long-term surveillance and treatment strategies.
2. How is the sample collected and what preparation is required?
A simple blood sample is collected from a vein in your arm. No fasting is necessary, but pre-test genetic counselling is mandatory. Our certified phlebotomist visits your preferred location daily from 8 AM to 11 PM, collects a small volume of whole blood, and transports it under strict cold-chain conditions to our ISO-accredited laboratory.
3. How long do results take and how are they interpreted?
Results are delivered within 3โ4 weeks and are interpreted by a DHA-licensed consultant medical geneticist. A report identifying a pathogenic variant confirms the diagnosis of thrombocytopenia type 2. A negative result reduces the likelihood of ANKRD26-related thrombocytopenia but does not eliminate all hereditary causes; your genetic counsellor will explain the implications and recommend next steps.
UAE Regulatory & Data Privacy Adherence
This service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical genetic testing and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility holds ISO 9001:2015 accreditation (Cert: INT/EGQ/2509DA/3139) and operates under DHA and MOHAP standard nomenclature.
Clinical & Logistical Metadata
| Test Name | ANKRD26 Gene Thrombocytopenia Type 2 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Peripheral whole blood |
| Methodology Used | Next-generation sequencing (NGS) โ full gene coverage |
| ICD-10-CM Code | D69.4 |
| LOINC Code | 21673-3 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No fasting required", "Pre-test genetic counselling is mandatory"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians